Clinical Trials Logo

Hearing Loss clinical trials

View clinical trials related to Hearing Loss.

Filter by:

NCT ID: NCT05299892 Completed - Clinical trials for Hearing Loss, Sensorineural

Optimizing Soft Speech Recognition in Children With Hearing Loss

SoftSpeech
Start date: March 21, 2022
Phase: N/A
Study type: Interventional

Overhearing is important for vocabulary learning and speech and language development in young children. However, contemporary hearing aids are generally unable to provide adequate access to low-level auditory inputs from multiple talkers at a distance to capitalize on overhearing. A recent investigation by Jace Wolfe and colleagues showed that, even when aided, children with hearing loss had significantly poorer speech recognition at 40, 50 and 60 dBA compared to children with normal hearing. Furthermore, they showed that increasing hearing aid gain for very low-level inputs produced a statistically significant improvement in syllable-final plural recognition and a non-significant trend toward better monosyllabic word recognition at very low presentation levels. Additional research is needed to document low-level speech recognition ability of children with hearing loss as well as the potential benefit or detriment of increasing hearing aid gain for low-level inputs. A novel hearing aid technology known as Soft Speech Enhancer has been shown improve low-level speech perception in adults with hearing loss; however, the effect of Speech Enhancer on speech recognition in children is not yet known and will be evaluated.

NCT ID: NCT05292534 Completed - Tinnitus Clinical Trials

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

NCT ID: NCT05286385 Completed - Clinical trials for Hearing Impairment, Sensorineural

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.

NCT ID: NCT05284903 Completed - Hearing Loss Clinical Trials

Hearing Aid Performance Study for Different Spatial Configurations

Start date: March 21, 2022
Phase: N/A
Study type: Interventional

This clinical investigation will extend the evaluation of perception of speech in different listening environments with hearing aids available on the market (from Phonak). The clinical investigation is divided in three parts addressing different challenges met by hearing aid users.

NCT ID: NCT05280808 Completed - Hearing Loss Clinical Trials

Evaluation of Software for Self-Fitting of Hearing Aids by People With Hearing Loss

Start date: March 18, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the efficacy of a prototype app for the self-fitting of hearing aids.

NCT ID: NCT05274178 Completed - Hearing Loss Clinical Trials

Effect of Hearing Aid Labeling on Speech Understanding Measures

Start date: May 26, 2022
Phase: N/A
Study type: Interventional

New and experienced hearing aid users will be fit with two hearing devices. One will be labeled as an OTC (Over-The-Counter) device, the other will be labeled as a Prescriptive (i.e. professionally fit) device. Both devices will be generically programmed for a mild to moderate hearing loss. An objective speech in noise test will be completed with both devices.

NCT ID: NCT05274165 Completed - Hearing Loss Clinical Trials

Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology

Start date: March 29, 2022
Phase: N/A
Study type: Interventional

Two groups of hearing aid candidates will be fit with extended wear technology. One group will be fit with the commercially available models, and the other group will be fit with either the commercially available model or a new model with different fitting characteristic. After an appropriate trial period, the success rate of each group will be determined by the desire to purchase devices.

NCT ID: NCT05270876 Completed - Hearing Loss Clinical Trials

Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

This study is to evaluate new approaches to device fitting and diagnostics for cochlear implant users. The evaluation can be performed in the laboratory in an acute session or in real world environments with take-home device use to further validate their benefits. Each feature will be tested in a sub-study specific to that hearing care model. On average, each sub-study is expected to include approximately 20 subjects.

NCT ID: NCT05265260 Completed - Clinical trials for Sensorineural Hearing Loss, Bilateral

Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults

PROGRESS
Start date: April 21, 2022
Phase:
Study type: Observational

The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.

NCT ID: NCT05260307 Recruiting - Hearing Loss Clinical Trials

Improving Spatial Perception and Speech Understanding in Multitalker Mixtures

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate several approaches for improving spatial perception and speech intelligibility in multitalker listening situations for hearing-aid users. The hypotheses are that spatial perception and speech intelligibility will be improved by (1) increased high-frequency audibility, (2) speech envelope enhancement, and/or (3) appropriate sound image externalization.